-
Mashup Score: 4Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years - 10 month(s) ago
NMV-r use for Covid-19 in vaccinated adults aged 18-50, with serious comorbidities, was associated with improved clinical outcomes. However, patients without si
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Trends In ST-elevation Myocardial Infarction Hospitalisation Among Young Adults: A Binational Analysis - 10 month(s) ago
AbstractBackground. ST-segment myocardial infarction (STEMI) is typically associated with increased age, but there is an important group of patients that suffer
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
RT @BartoszHudzik: ⬆️ proportions of #women, #ethnic #minorities & #T2DM among #young #STEMI pts 👉 https://t.co/JuFHYdtXuL #EHJCQCCO #CVD @…
-
-
Mashup Score: 3
These findings provide evidence that continuous glucose monitoring can reduce severe hypoglycaemia and ketoacidosis risk in young people with type 1 diabetes on insulin therapy. Continuous glucose monitoring metrics might help to identify those at risk for acute diabetes complications.
Categories: Endocrinology, Latest HeadlinesTweet-
Online first: Continuous glucose monitoring versus blood glucose monitoring for risk of severe #hypoglycaemia and #diabetic #ketoacidosis in #children, #adolescents, and #young adults with type 1 #diabetes: a population-based study https://t.co/q1xKzEgffn #CGM #DKA #T1D
-
-
Mashup Score: 4
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Efficacy and safety of the #SGLT2 inhibitor #empagliflozin vs placebo and the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO1cyU #T2D #youth
-
-
Mashup Score: 1Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Sten Madsbad comments on: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D #youth
-
-
Mashup Score: 0
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Efficacy and safety of the #SGLT2 inhibitor #empagliflozin vs placebo & the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO1cyU #T2D #youth
-
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Sten Madsbad comments on: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D #youth
-
-
Mashup Score: 10Colorectal Cancer in Young Black Americans | The Association of Black Gastroenterologists and Hepatologists (ABGH) - 1 year(s) ago
James Casey, a current member of Trey Anastasio Band, had performed, recorded, produced and written with many of the world’s leading and most influential artists. As a patient advocate diagnosed […]
Categories: Gastroenterology, Latest HeadlinesTweet-
#ColorectalCancer is “the third most common in cancer deaths... Black people really have the highest rates, this is why we are here.” -- @vgustavemd said during @blackingastro ‘s Colorectal Cancer in Young Black Americans event https://t.co/0VKZUATd5P #ColorectalCancerAwarenes https://t.co/eYeIeQITNL
-
“Our goal is not only that you learn something today but really feel empowered to make a difference in the lives of your community” - @realDoctorUgo said during @blackingastro ‘s Colorectal Cancer in Young Black Americans event https://t.co/0VKZUATd5P #ColorectalCancerAwareness https://t.co/EE4Ecptk8z
-
HAPPENING NOW! @blackingastro presents "#ColorectalCancer in #Young #Black #Americans" featuring #expert commentary from @vgustavemd and real-life stories from @JamesCaseySax (moderated by @realDoctorUgo). Check it out now: https://t.co/0VKZUATd5P https://t.co/MR8lRo5D8h
-
Reporting live from #ColorectalCancer in Young Black Americans … follow along as @HealioGastro - official media partner of @blackingastro - covers the reality of early age onset colorectal cancer in the Black community. https://t.co/0VKZUATd5P #GITwitter #MedTwitter https://t.co/hMgIhYzV3s
-
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the Linked Comment by Sten Madsbad: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D
-
-
Mashup Score: 1
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Efficacy and safety of the #SGLT2 inhibitor #empagliflozin versus placebo and the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (#DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO0EJm #T2D
-
Our Study @CIDJournal led by @jeremyfaust @PaulSaxMD #Paxlovid for Covid-19 in #Young (18-50) Vaccinated Patients with comorbidities (ie #CVD #Cancer #cardioonc) requiring frequent healthcare improves outcomes⬇️#death #hospitalization #Emergency visits https://t.co/tkdeV0XFNv